Despite the different doses of semaglutide and tirzepatide and timepoints studied, the results of SURMOUNT-5 and the Truveta Research study were consistent, namely that tirzepatide-based medications performed better than semaglutide-based medications: SURMOUNT-5 study : At 72 weeks, weight loss was 20.2% for Zepbound (tirzepatide AOM) compared to 13.7% for Wegovy (semaglutide AOM)
it contributes to sustained satiety, which is further enhanced by GLP-1 medications, helping to prevent overeating and support consistent weight loss
We're beyond thrilled to hear about your successful journey
10.1124/jpet.115.225698 78 YangS
Colloquially, these changes are referred to on social media as semaglutide face or Ozempic face, based on the commercial names of semaglutide
Supersized portions, while appealing for some, are not going to work for the typical GLP-1 patient whose appetite will shrink on the drug